Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-25-088878

Director sold 2,405 shares at $37.39 ($89,923)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sanders Corazon (Corsee) D. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-20 Sale : show line 1 in the form 10b5-1 −2,405 $37.39 $89,923 15,344 D
Open-market sales · 2,405 sh · avg $37.39 · $89,923
Loading xslF345X05/ownership.xml…